Atara Biotherapeutics (ATRA) ATA188 Likely To Progress to Ph2 - William Blair Sep 16, 2019 09:29AM
William Blair Reiterates Outperform Rating on Atara Biotherapeutics (ATRA) Jul 16, 2019 12:18PM
Atara Biotherapeutics to Participate in Upcoming Conferences Mar 7, 2019 09:00AM
Atara Biotherapeutics to Participate in Upcoming Conferences Mar 7, 2019 09:00AM
Atara Biotherapeutics to Participate in Three Upcoming Immuno-Oncology Conferences Mar 22, 2018 04:30PM


Mar 22, 2018 04:30PM Atara Biotherapeutics to Participate in Three Upcoming Immuno-Oncology Conferences
Jan 4, 2018 05:48AM ATARA Biotherapeutics (ATRA) Prices 7M Share Common Offering at $18.25/Sh
Jan 3, 2018 10:55PM Atara Biotherapeutics Announces Pricing of Public Offering of Common Stock
Jan 3, 2018 10:55PM Atara Biotherapeutics Announces Pricing of Public Offering of Common Stock
Sep 15, 2016 10:27AM Notable Analyst Rating Changes 9/15: (GPN) (AKRX) (EXTR) Upgraded; (VFC) (FGP) (ATRA) Downgraded
Mar 28, 2016 04:05PM Atara Bio Announces Participation in Two Upcoming Immuno-Oncology Conferences
Oct 9, 2015 07:30AM William Blair Starts Atara Biotherapeutics (ATRA) at Outperform
Jul 15, 2015 11:24AM Atara Bio Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jul 10, 2015 06:49AM ATARA Biotherapeutics (ATRA) Prices 3.46M Common Stock Offeirng at $52/Share
Jul 9, 2015 08:08PM Atara Bio Announces Pricing of Its $180.0 Million Offering of Common Stock
Jul 7, 2015 04:06PM Atara Biotherapeutics (ATRA) Announces $125M Common Stock Offering
Jul 7, 2015 04:05PM Atara Bio Announces Proposed Offering of Common Stock